Kangmei Pharmaceutical: A Chinese Lesson on Investor Protection
By Mak Yuen Teen and Wesley Loo Kangmei Pharmaceutical Co. (“Kangmei”), a Fortune China 500 company in 2018[1], was a large Chinese medicine producer based in Guangdong province[2]. Its primary business revolved around the...
Read More